Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHEFT.L Regulatory News (HEFT)

  • There is currently no data for HEFT

Share Split

8 Dec 2021 17:08

RNS Number : 0362V
Henderson European Focus Trust PLC
08 December 2021
 

HENDERSON EUROPEAN FOCUS TRUST PLC

 

HENDERSON INVESTMENT FUNDS LIMITED

 

LEGAL ENTITY IDENTIFIER: 213800GS89AL1DK3IN50

 

8 December 2021

 

HENDERSON EUROPEAN FOCUS TRUST PLC

Share Split

Henderson European Focus Trust plc (the "Company") has today published its annual report and accounts for the year ended 30 September 2021 which also contains details of the proposed sub-division of the Company's ordinary shares (the "Share Split").

The Company is proposing to undertake the Share Split by subdividing each ordinary share of 50 pence ("Existing Ordinary Shares") into ten new ordinary shares of 5 pence each ("New Ordinary Shares") subject to shareholder approval of the Share Split at the Company's Annual General Meeting, which will be held on Thursday, 27 January 2022 at 2.30 pm. The Share Split is intended to improve the liquidity of the Company's shares and enhance the ability of investors to make more efficient regular monthly investments on share dealing platforms.

 

The Share Split is also conditional on the New Ordinary Shares being admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities (together, "Admission"). Applications for Admission will be made in due course and it is expected that Admission will become effective, and that dealings in the New Ordinary Shares will commence, at 8.00 am on Monday, 7 February 2022, at which time the Share Split will become effective. The last day of trading in the Existing Ordinary Shares is expected to be Friday, 4 February 2022 and the record date for the Share Split is 6.00 pm on that date (the "Record Date").

 

Shareholders will receive ten New Ordinary Shares in exchange for each Existing Ordinary Share held at the Record Date. CREST accounts are expected to be credited with New Ordinary Shares on Monday, 7 February 2022 and share certificates in respect of the New Ordinary Shares are expected to be posted to shareholders no later than 21 February 2022.

 

The New Ordinary Shares will retain the ticker of the Existing Ordinary Shares (being HEFT) but will have a new ISIN and SEDOL as follows:

 

New ISIN: GB00BLSNGB01

 

New SEDOL: BLSNGB0

 

The New Ordinary Shares will rank pari passu with each other and will be subject to the same rights and restrictions as the Existing Ordinary Shares. A holding of New Ordinary Shares following the sub-division will represent the same proportion of the issued ordinary share capital of the Company as the corresponding holding of Existing Ordinary Shares.

 

 

For further information, please contact:

 

Neil Morgan

Winterflood Investment Trusts

Corporate Broker

Telephone: 020 3100 0292

Johana Woodruff

For and on behalf of

Henderson Secretarial Services Limited

Corporate Secretary

Telephone: 020 7818 2220

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCEAXAPEESFFFA
Date   Source Headline
16th Feb 202312:40 pmRNSNet Asset Value(s)
15th Feb 202311:51 amRNSNet Asset Value(s)
14th Feb 202311:23 amRNSNet Asset Value(s)
13th Feb 20234:13 pmRNSNet Asset Value(s)
10th Feb 202312:39 pmRNSNet Asset Value(s)
9th Feb 202312:23 pmRNSNet Asset Value(s)
8th Feb 202312:45 pmRNSDirector/PDMR Shareholding
8th Feb 202312:39 pmRNSNet Asset Value(s)
7th Feb 202312:18 pmRNSNet Asset Value(s)
6th Feb 20232:29 pmRNSNet Asset Value(s)
3rd Feb 202311:38 amRNSNet Asset Value(s)
2nd Feb 202312:35 pmRNSNet Asset Value(s)
1st Feb 20232:27 pmRNSNet Asset Value(s)
31st Jan 20231:23 pmRNSNet Asset Value(s)
30th Jan 20231:57 pmRNSNet Asset Value(s)
27th Jan 20231:47 pmRNSNet Asset Value(s)
26th Jan 20235:57 pmRNSResult of AGM
26th Jan 202312:07 pmRNSNet Asset Value(s)
25th Jan 202310:53 amRNSNet Asset Value(s)
24th Jan 202311:58 amRNSNet Asset Value(s)
23rd Jan 20232:20 pmRNSNet Asset Value(s)
23rd Jan 202311:17 amRNSMonthly Factsheet as at 31 December 2022
20th Jan 20235:00 pmRNSDirector/PDMR Shareholding
20th Jan 202312:24 pmRNSNet Asset Value(s)
19th Jan 202312:07 pmRNSNet Asset Value(s)
18th Jan 20234:36 pmRNSNet Asset Value(s)
16th Jan 20231:53 pmRNSNet Asset Value(s)
13th Jan 202312:51 pmRNSNet Asset Value(s)
12th Jan 202312:18 pmRNSNet Asset Value(s)
11th Jan 202311:57 amRNSNet Asset Value(s)
10th Jan 202311:21 amRNSNet Asset Value(s)
9th Jan 20234:25 pmRNSNet Asset Value(s)
6th Jan 202312:54 pmRNSNet Asset Value(s)
5th Jan 202312:15 pmRNSNet Asset Value(s)
4th Jan 202312:08 pmRNSNet Asset Value(s)
3rd Jan 20233:49 pmRNSNet Asset Value(s)
3rd Jan 20239:34 amRNSBlock listing Interim Review
30th Dec 202212:53 pmRNSNet Asset Value(s)
29th Dec 202212:52 pmRNSNet Asset Value(s)
28th Dec 202212:54 pmRNSNet Asset Value(s)
23rd Dec 202211:16 amRNSNet Asset Value(s)
22nd Dec 20223:22 pmRNSMonthly Factsheet as at 30 November 2022
22nd Dec 202211:48 amRNSNet Asset Value(s)
21st Dec 202212:32 pmRNSNet Asset Value(s)
20th Dec 202211:22 amRNSNet Asset Value(s)
19th Dec 20223:04 pmRNSNet Asset Value(s)
16th Dec 202211:16 amRNSNet Asset Value(s)
16th Dec 202210:52 amRNSDoc re. Annual Financial Report
15th Dec 202212:05 pmRNSNet Asset Value(s)
14th Dec 202212:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.